RECURRENT GLIOBLASTOMA
Clinical trials for RECURRENT GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for RECURRENT GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New immune drug targets deadly brain tumors in early trial
Disease control Not yet recruitingThis early-phase study tests a new drug called BRiTE in 18 adults with a severe brain cancer (glioblastoma) that has a specific genetic marker (EGFRvIII). The drug is designed to help the body's immune cells attack the tumor. It is given as a continuous IV infusion over 4 days ea…
Matched conditions: RECURRENT GLIOBLASTOMA
Phase: PHASE1 • Sponsor: Mustafa Khasraw, MBChB, MD, FRCP, FRACP • Aim: Disease control
Last updated May 26, 2026 05:12 UTC
-
Diabetes drug takes on deadly brain tumors in new trial
Disease control Not yet recruitingThis early-phase trial tests whether sitagliptin, a common diabetes pill, can help treat a severe brain cancer (grade 4 glioma) that has returned after standard therapy. About 45 adults will receive sitagliptin alongside the standard drug bevacizumab. The main goals are to find t…
Matched conditions: RECURRENT GLIOBLASTOMA
Phase: PHASE1 • Sponsor: Kailin Yang, MD, PhD • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
Supercharged immune cells take on deadly brain tumors
Disease control Not yet recruitingThis early-phase trial tests a new way to treat glioblastoma that has come back after standard therapy. Doctors will deliver specially engineered natural killer (NK) cells directly into the brain to attack the tumor. The study includes 36 adults and aims to find the safest dose a…
Matched conditions: RECURRENT GLIOBLASTOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 13, 2026 16:00 UTC